Effect of phellinus polysaccharide on canonical Wnt signaling in synovium in rats with rheumatoid arthritis

Journal of Sichuan University (Medical Science Edition)

Volumn 46, Issue 3, 2015, Pages 376-379

  Miao, Cheng Gut ^a,b   Zhou, Guo Liang ^b   Qin, Mei Song ^b   Chen, Jian Zhong ^b   Li, Cheng Feng ^b  

^a ANHUI SCIENCE AND TECHNOLOGY UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Canonical Wnt signaling; Phellinus polysaccharide; Rheumatoid arthritis; catenin C myc

Indexed keywords

POLYSACCHARIDE;

ANIMAL; ARTHRITIS, RHEUMATOID; BASIDIOMYCETES; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; SYNOVIUM; WNT SIGNALING PATHWAY;

ANIMALS; ARTHRITIS, RHEUMATOID; BASIDIOMYCOTA; DISEASE MODELS, ANIMAL; MALE; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; WNT SIGNALING PATHWAY;

EID: 84931024701     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Huang YJ, Shiau AL, Chen SY, et al. Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering. Eur Cell Mater, 2012, 13(23):170-181.
2. Tedesco A, D'Agostino D, Soriente I, et al. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Autoimmun Rev, 2009;8(3):233-237.
3. Miao CG, Yang YY, He X, et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal, 2013;25(10):2069-2078.
4. Sen M, Reifert J, Lauterbach K, et al. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum, 2002;46(11):2867-2877.
5. Tracey D, Klareskog L, Sasso EH, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther, 2008;117(6):244-279.
6. Chang JT, Lichtenstein GR. Drug insight: antagonists of tumor-necrosis factoralpha in the treatment of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol, 2006;3(2):220-228.
7. Feldmann M, Brennan FM, Williams RO, et al. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis. Best Pract Res Clin Rheumatol, 2004;18(8):59-80.
8. Stock M, Bohm C, Scholtysek C, et al. Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor α-mediated experimental arthritis. Arthritis Rheum, 2013;65(9):2310-2322.
9. Lories RJ, Corr M, Lane NE. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol, 2013;9(6):328-339.
10. Lazarova DL, Chiaro C, Bordonaro M. Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells. BMC Res Notes, 2014;7:226. doi: 10. 1186/1756-0500-7-226.